NCT06569381 Comparative Pharmacokinetic Study of Pirfenidone Modified-Release Tablets in Healthy Subjects Under Fasting and Fed Conditions Status COMPLETED Phase PHASE1
NCT06567717 Zinc and Nicotinamide Riboside for Idiopathic Pulmonary Fibrosis Status RECRUITING Phase PHASE2
NCT06521125 Clinical Genetics and Screening for Idiopathic Pulmonary Fibrosis Status NOT_YET_RECRUITING Phase N/A
NCT06488638 Pilot Study of Nitrate-rich Beetroot Juice Supplementation in Patients With Idiopathic Pulmonary Fibrosis (IPF) Status RECRUITING Phase NA
NCT06482190 A Study to Evaluate Safety, Tolerability and Pharmacokinetics of RSN0402 in Healthy Volunteers Status RECRUITING Phase PHASE1
NCT06445686 Ongoing Monitoring of Vital Signs in Patients With Idiopathic Pulmonary Fibrosis Before and After Acute Exacerbation. Status RECRUITING Phase N/A
NCT06422884 A Phase 2 Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06360094 A Study to Test Whether BI 1839100 Improves Cough in People With Idiopathic Pulmonary Fibrosis or Progressive Pulmonary Fibrosis Status TERMINATED Phase PHASE2
NCT06335303 A Study to Test Whether BI 1819479 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) Status COMPLETED Phase PHASE2
NCT06331624 Biomarker Modulation and the Inhibition of NKT1 Cells by Oral GRI-0621 in Patients With IPF Status COMPLETED Phase PHASE2
NCT06325696 H01 in Adults With Interstitial Lung Disease (The SOLIS Study) Status RECRUITING Phase PHASE2
NCT06323876 The Role of Quantitative CT and Radiomic Biomarkers for Precision Medicine in Pulmonary Fibrosis Status RECRUITING Phase N/A
NCT06317285 A Study to Evaluate the Efficacy and Safety of GSK3915393 in Participants With Idiopathic Pulmonary Fibrosis (IPF) Status TERMINATED Phase PHASE2
NCT06267183 A Clinical Study to Evaluate Safety, Tolerability and Pharmacokinetics of SV001 in Chinese Healthy Adult Volunteers. Status RECRUITING Phase EARLY_PHASE1
NCT06265532 Collagen-targeted Positron Emission Tomography (PET) Imaging for Assessment of EGCG Effect Status COMPLETED Phase PHASE1
NCT06241560 A Study in People With Idiopathic Pulmonary Fibrosis to Test Whether Pirfenidone Influences the Amount of BI 1015550 in the Blood Status COMPLETED Phase PHASE2
NCT06238622 A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast Status RECRUITING Phase PHASE3
NCT06230822 Safety, Tolerability and Efficacy of VUM02 Injection in Treatment of Idiopathic Pulmonary Fibrosis (IPF) Status COMPLETED Phase PHASE1